Author:
Coleman R.,Woodward E.,Brown J.,Cameron D.,Bell R.,Dodwell D.,Keane M.,Gil M.,Davies C.,Burkinshaw R.,Houston S. J.,Grieve R. J.,Barrett-Lee P. J.,Thorpe H.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN2002: cancer incidence, mortality and prevalence worldwide. IARCpress, Lyon [06/01/2010]. Available from: http://www-dep.iarc.fr/
2. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC (2009) Early breast cancer. Lancet 373:1463–1479
3. Ottewell PD, Monkkonen H, Jones M, Lefley DV, Coleman RE, Holen I (2008) Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer. J Natl Cancer Inst 100:1167–1178
4. Neville-Webbe HL, Rostami-Hodjegan A, Evans CA, Coleman RE, Holen I (2005) Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells. Int J Cancer 113:364–371
5. Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Postlberger S, Menzel C et al (2009) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679–691
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献